Adaptation of rat fast-twitch muscle to endurance activity is underpinned by changes to protein degradation as well as protein synthesis. by Hesketh, SJ et al.
 Hesketh, SJ, Sutherland, H, Lisboa, PJ, Jarvis, JC and Burniston, JG
 Adaptation of rat fast-twitch muscle to endurance activity is underpinned by 
changes to protein degradation as well as protein synthesis.
http://researchonline.ljmu.ac.uk/id/eprint/13275/
Article
LJMU has developed LJMU Research Online for users to access the research output of the 
University more effectively. Copyright © and Moral Rights for the papers on this site are retained by 
the individual authors and/or other copyright owners. Users may download and/or print one copy of 
any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities or 
any commercial gain.
The version presented here may differ from the published version or from the version of the record. 
Please see the repository URL above for details on accessing the published version and note that 
access may require a subscription. 
For more information please contact researchonline@ljmu.ac.uk
http://researchonline.ljmu.ac.uk/
Citation (please note it is advisable to refer to the publisher’s version if you 
intend to cite from this work) 
Hesketh, SJ, Sutherland, H, Lisboa, PJ, Jarvis, JC and Burniston, JG (2020) 
Adaptation of rat fast-twitch muscle to endurance activity is underpinned by 
changes to protein degradation as well as protein synthesis. FASEB 
Journal. ISSN 1530-6860 
LJMU Research Online
The FASEB Journal. 2020;00:1–20.    | 1wileyonlinelibrary.com/journal/fsb2
Received: 20 March 2020 | Revised: 14 May 2020 | Accepted: 21 May 2020
DOI: 10.1096/fj.202000668RR  
R E S E A R C H  A R T I C L E
Adaptation of rat fast-twitch muscle to endurance activity is 
underpinned by changes to protein degradation as well as protein 
synthesis
Stuart J. Hesketh1 |   Hazel Sutherland1 |   Paulo J. Lisboa3 |   Jonathan C. Jarvis1 |    
Jatin G. Burniston1,2
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, 
provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology
Abbreviations: 2DGE, two dimensional gel electrophoresis; 2H, deuterium; 2H2O, deuterium oxide; AATC, aspartate aminotransferase, cytoplasmic; 
AATM, aspartate aminotransferase, mitochondrial; ABD, abundance; ABR, abundance rate; ACADL, long-chain specific acyl-CoA dehydrogenase, 
mitochondrial; ACON, aconitate hydratase, mitochondrial; ACTH, adrenocorticotropic hormone; ACTN1, alpha-actinin-1; ACTS/ACTC, actin, alpha 
skeletal muscle/ Actin, alpha cardiac muscle 1; ADH-1, alcohol dehydrogenase 1; ADR, absolute degradation rate; ALBU, serum albumin; ALDOA, 
fructose-bisphosphate aldolase A; ALDR, aldo-keto reductase family 1 member B1; ANXA4, annexin A4; ASR, absolute synthesis rate; AT2A2, 
sarcoplasmic/endoplasmic reticulum calcium ATPase 2; ATPA, ATP synthase subunit alpha, mitochondrial; ATPase, ATP synthase; ATPB, ATP synthase 
subunit beta, mitochondrial; ATPO, ATP synthase subunit O, mitochondrial; BSA, bovine serum albumin; Ca2+, calcium ion; CAH3, carbonic anhydrase 3; 
CASQ1, calsequestrin-1; CHAPS, 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate; CLFS, Chronic low-frequency stimulation; 
CRYAB, alpha-crystallin B chain; Ctrl, non-stimulated contralateral control limb/muscle; CV, coefficient of variation; CX7A2, cytochrome c oxidase 
subunit 7A2, mitochondrial; DESM, desmin; DPP, dynamic proteome profiling; DTT, dithiothreitol; EDL, extensor digitorium longus; ENOB, beta-enolase; 
ESI-Q-TOF, electrospray ionisation quadrupole time of flight; FASP, filter aided sample preparation; FDL, flexor digitorium longus; FDR, false discovery 
rate; FHL1, four and a half LIM domains protein 1; FSR, fractional synthesis rate; G3P, glyceraldehyde-3-phosphate dehydrogenase; GC-MS, gas 
chromatography mass spectrometry; HBA, hemoglobin subunit alpha-1/2; HBB1, hemoglobin subunit beta-1; HBB2, hemoglobin subunit beta-2; HCl, 
hydrochloric acid; HSPB6, heat shock protein beta-6; IDH3A, isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial; IDHP, isocitrate 
dehydrogenase [NADP], mitochondrial; IPG, immobilised pH gradient; k, synthesis rate constant; KAD1, adenylate kinase isoenzyme 1; KCRB, creatine 
kinase B-type; KCRM, creatine kinase M-type; KCRS, creatine kinase S-type, mitochondrial; KPYM, pyruvate kinase PKM; LC-MS, liquid 
chromatography mass spectrometry; LC-MS/MS, liquid chromatography mass spectrometry/mass spectrometry; LDHA, L-lactate dehydrogenase A chain; 
m0, monoisotopic peak; m1, m2, m3, heavy isotopomers; MALDI-TOF, Matrix-assisted laser desorption/ionization-time of flight; MALDI-TOF/MS, 
matrix-assisted laser desorption/ionization-time of flight/mass spectrometry; MDHC, malate dehydrogenase, cytoplasmic; MDHM, malate dehydrogenase, 
mitochondrial; MLRS, myosin regulatory light chain 2, skeletal muscle isoform; MLRV, myosin regulatory light chain 2, ventricular/cardiac muscle 
isoform; Mr, relative molecular mass; MS, mass spectrometry; MS/MS, tandem mass spectrometry; MyHC, myosin heavy chain; MYG, myoglobin; MYL1, 
myosin light chain 1/3, skeletal muscle isoform; MYL3, myosin light chain 3; n, number of exchangeable deuterium/hydrogen sites; NC, no change; NS, not 
significant; ODPA, pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial; p, precursor enrichment; PARK7, protein/nucleic 
acid deglycase DJ-1; PFKAM, ATP-dependent 6-phosphofructokinase, muscle type; PGAM2, phosphoglycerate mutase 2; PGK1, phosphoglycerate kinase 
1; PGM1, phosphoglucomutase-1; Phospho S/T, phosphorylation of serine/threonine; pI, isoelectric point; PLEC, plectin; Proteo-ADPT, absolute dynamic 
profiling technique for proteomics; PRVA, parvalbumin alpha; PYGB, glycogen phosphorylase, brain form; PYGM, glycogen phosphorylase, muscle form; 
SAFB1, scaffold attachment factor B1; SERCA, sarcoplasmic/endoplasmic reticulum calcium ATPase; SD, standard deviation; SDS, sodium dodecyl 
sulfate; Stim, stimulated limb/muscle; TA, tibialis anterior; TFA, trifluoroacetic acid; TIC, total ion chromatogram; TNNI1, troponin I, slow skeletal muscle; 
TNNI2, troponin I, fast skeletal muscle; TNNT1, troponin T, slow skeletal muscle; TNNT3, troponin T, fast skeletal muscle; TPIS, triosephosphate 
isomerase; TPM2, tropomyosin beta chain; TPM4, tropomyosin alpha-4 chain; UPLC, ultra performance liquid chromatography; VDAC, voltage-dependent 
anion channel.
1Research Institute for Sport & Exercise 
Sciences, Liverpool John Moores 
University, Liverpool, UK
2Liverpool Centre for Cardiovascular 
Science, Liverpool John Moores University, 
Liverpool, UK
3Department of Applied Mathematics, 
Abstract
Muscle adaptations to exercise are underpinned by alterations to the abundance of 
individual proteins, which may occur through a change either to the synthesis or 
degradation of each protein. We used deuterium oxide (2H2O) labeling and chronic 
low-frequency stimulation (CLFS) in vivo to investigate the synthesis, abundance, 
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1 |  INTRODUCTION
The adaptation of muscle to contractile activity underpins 
many of the health benefits of exercise and is a longstand-
ing focus of interest in physiology. For example, endurance 
training profoundly alters substrate utilization and insulin 
sensitivity in muscle, and, thereby, has a positive impact on 
whole-body metabolism, disease risk, and aging. Proteins are 
the principal cellular components that determine the func-
tional attributes of individual muscle fibres, including speed 
of contraction, fatigue resistance, and metabolism. Skeletal 
muscle adapts to exercise through quantitative changes in 
size and protein composition. Changes to the abundance of 
muscle proteins induced by exercise are long-established1 
and we have used non-targeted proteomics to investigate 
broad changes in muscle protein abundance of rats2 and hu-
mans3 in response to exercise training. Such profiling of pro-
tein abundance or posttranslational modifications captures 
detailed information on specific cell states. For example, 
protein abundance data has been incorporated into metabolic 
models4 to reveal novel insights regarding energy metabolism 
during high-intensity exercise. Nevertheless, profiling of pro-
tein abundance data or protein posttranslational states do not 
capture dynamic aspects of the proteome, such as protein 
turnover, and cannot explain how changes in protein abun-
dance are brought about in exercise-trained muscle.
Changes to protein abundance can only occur because 
proteins are dynamic and exist in a continuous cycle of syn-
thesis and degradation, termed protein turnover. Protein turn-
over has long been studied using stable isotope-labeled amino 
acids in vivo and measurements of isotope enrichment in tis-
sue amino acids5 by gas-chromatography mass spectrometry 
(GC-MS). Exercise is a potent stimulus of protein synthesis 
in skeletal muscle and resistance and endurance exercise may 
regulate the synthesis of different populations of muscle pro-
teins.6 In humans, the fractional synthetic rate of mixed my-
ofibrillar proteins is doubled 3 hours after an acute bout of 
resistance exercise7 and the average turnover of proteins in 
endurance-trained muscle is 20% greater than in sedentary 
controls.8 However, such data on average responses in mixed 
protein samples cannot distinguish whether, for example, the 
synthesis of all proteins increased by 50% or the synthesis of 
50% of proteins was doubled. Recently, peptide mass spec-
trometry techniques have been combined with deuterium 
oxide labeling in vivo to generate data on the fractional syn-
thesis rate (FSR) of individual proteins.9 We developed this 
method further by incorporating protein abundance mea-
surements,5 which enabled increases in protein turnover to 
be distinguished from net increases in synthesis that lead to 
an accretion of new protein. Moreover, the measurement of 
protein abundance alongside protein-specific synthesis rates 
affords new opportunities to study protein dynamics in sys-
tems that are undergoing change.10
When measured at the level of individual proteins, 
changes in protein abundance that are not matched by 
equivalent changes to the synthetic rate of the protein 
may be attributed to protein degradation. In human mus-
cle, we10 reported protein-specific responses to resistance 
exercise, including proteins that changed in turnover rate 
without changing in abundance, and proteins that increased 
in abundance due to changes in the balance between deg-
radation and synthesis. Our findings included proteins 
such as filamin C, whose increase in abundance after re-
sistance exercise training without a measurable change in 
synthesis rate may, therefore, be attributed to a decrease in 
degradation rate. During the short 9-day investigation of 
resistance exercise training,10 the majority of proteins that 
were responsive to exercise responded by increasing their 
turnover rate. For example, type IIa myosin heavy chain 
(MyHC) turnover was selectively increased during the first 
few sessions of resistance exercise, which may be a pre-se-
quel to the expected increase in type IIa MyHC abundance 
after sustained (eg, 16-week11) periods of training. Longer 
duration training studies are more likely to be associated 
with concomitant changes in muscle mass, which could 
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and degradation of individual proteins during exercise-induced muscle adaptation. 
Independent groups of rats received CLFS (10 Hz, 24 h/d) and 2H2O for 0, 10, 20, or 
30 days. The extensor digitorum longus (EDL) was isolated from stimulated (Stim) 
and contralateral non-stimulated (Ctrl) legs. Proteomic analysis encompassed 38 my-
ofibrillar and 46 soluble proteins and the rates of change in abundance, synthesis, and 
degradation were reported in absolute (ng/d) units. Overall, synthesis and degrada-
tion made equal contributions to the adaptation of the proteome, including instances 
where a decrease in protein-specific degradation primarily accounted for the increase 
in abundance of the protein.
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confound the interpretation of dynamic proteome profiling 
data reported in relative protein abundances and fractional 
rates of protein synthesis. Without the ability to provide 
information in absolute units it may not be possible to gain 
an entirely accurate understanding of the contributions that 
synthesis and degradation make to changes in the abun-
dance of individual proteins.
In this paper, in contrast, we used an Absolute Dynamic 
Profiling Technique (ADPT) for proteomics, nicknamed 
“Proteo-ADPT” to measure protein abundances (ng) within 
the entire extensor digitorum longus (EDL) and report 
absolute rates (ng/d) of synthesis and degradation on a 
protein-by-protein basis. Adaptations to rat EDL were inves-
tigated during a 30-d period of unilateral chronic low-fre-
quency stimulation (CLFS) in vivo. CLFS of rat fast-twitch 
muscle is a model of muscle transformation that has been 
widely used to investigate muscle plasticity.12 CLFS provides 
uniform recruitment of muscle motor units and results in 
well-established time-dependent changes in the molecular, 
structural and functional properties of muscle.13 The response 
of fast-twitch muscle to CLFS is similar to, but extends be-
yond the outcomes achieved by exercise models such as in-
tensity-controlled treadmill running.2 Unilateral stimulation 
of rat hindlimb dorsiflexor muscles in vivo provides stimu-
lated and contralateral control muscles from each individual 
animal. In the current work, muscles were collected from in-
dependent groups of rats (n  =  3, in each group) at 10-day 
intervals to enable high-quality data on isotope incorporation 
into proteins to be fitted to a single exponential model.5 In 
rats, deuterium enrichment of the body water compartment 
occurs rapidly (within 30 minutes) after a bolus injection and 
can be maintained at a steady state by supplementation of the 
animals’ drinking water, which simplifies protein synthesis 
calculations compared to studies in humans.14 “Top-down” 
and “bottom-up” proteomic approaches were used to exploit 
the strengths of each technique. The myofibrillar proteome 
consists of numerous slow- and fast- isoforms which ex-
hibit complex patterns of splice variation and posttransla-
tional modification that are responsive to exercise training.2,3 
Therefore, myofibrillar proteoforms were resolved by 2-di-
mensional gel electrophoresis (2DGE) and spot densities 
were converted to absolute values.15 Metabolic enzymes ex-
hibit less complex proteoform responses to exercise and are 
more amenable to analysis at the peptide level, which offers 
broader inclusion of proteins at the extremes of MW and pI 
ranges. Therefore, abundances of soluble proteins were mea-
sured by spiking tryptic digests with yeast peptides prior to 
liquid chromatography tandem mass spectrometry (LC-MS/
MS), which facilitates reporting of absolute protein data.16 
Proteo-ADPT enabled us to measure protein abundances (ng) 
of the entire EDL muscle and report absolute rates (ng/d) 
of synthesis and degradation on a protein-by-protein basis. 
Herein, we provide new insight to the processes underlying 
muscle adaptation. Our findings indicate protein degradation 
and synthesis make approximately equal contributions to the 
overall change in muscle phenotype. At the level of individ-
ual proteins, the response to the chronic endurance stimulus 
included instances where degradation rate was the primary 
factor underpinning an increase in protein abundance. 
Conversely, some individual decreases in protein abundance 
occurred primarily via a decrease in synthesis rate.
2 |  MATERIALS AND METHODS
2.1 | Animals and experimental design
Experimental procedures were conducted under the British 
Home Office Animals (Scientific Procedures) Act 1986. 
Male Wistar rats (500 ± 69 g body weight; n = 12) were bred 
in-house in a conventional colony, housed in controlled con-
ditions of 20°C, 45% relative humidity, and a 12 hours light 
(0600-1800 hours) and 12 hours dark cycle, with water and 
food available ad libitum.
Animals were assigned to four groups (n  =  3 in each), 
including a sham-operated control group and three groups 
that received chronic low-frequency stimulation (CLFS; 
10  Hz) of the left hindlimb dorsiflexor muscles, as de-
scribed previously by our group.13 Surgery was performed 
with aseptic precautions and the animals were anesthetized 
using a gaseous mixture of isoflurane and O2. Buprenorphine 
(Temgesic, Indivior, Slough, UK) at a dose of 0.05  mg/
kg−1 body mass, was administered pre-surgery for analge-
sia. Implantable stimulators were used according to Salmons 
and Jarvis17 with minor modifications. Fine multi-stranded 
stainless-steel leads (Cooner Wire Assoc., Chatsworth, CA) 
were taken subcutaneously from the stimulator in the flank to 
just proximal to the knee on the left hind limb, the electrodes 
were fixed in close relationship to, but not in physical contact 
with, the common peroneal nerve. The body of the stimulator 
was situated in the abdominal cavity and held in place by 
suturing an integral Dacron mesh tag into the closure of the 
abdominal wall. The postoperative recovery of the animals 
was monitored daily for 1  week prior to commencing the 
stimulation protocol. The 0-day experimental time-point rep-
resents the sham-operated control group that were implanted 
with inactive stimulators and then, euthanized 1 week later. 
The remaining (10, 20, and 30 days) experimental groups had 
the stimulator activated non-invasively via an optical signal 
through the skin to a phototransistor in the device. Stimulation 
was initiated from day 0 at a continuous 10 Hz of the fast 
dorsiflexor muscles of the anterior compartment of the hind 
limb, including the EDL. Simultaneously, deuterium oxide 
(2H2O; Sigma-Aldrich, St. Louis, MO) administration was 
initiated by an intraperitoneal loading injection of 10 µL/g 
99% 2H2O-saline, and then, maintained by administration of 
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5% (v/v) 2H2O in the drinking water available to the rats, as 
described previously.18
After 10, 20, and 30 days of CLFS and 2H2O consump-
tion, animals were euthanized in a rising concentration of 
CO2 followed by cervical dislocation. EDL muscles from 
the left stimulated limb (Stim) and the right non-stimulated 
limb (Ctrl) were isolated. Each muscle was cleaned of fat and 
connective tissue then weighed before being frozen in liquid 
nitrogen and stored at −80°C pending further analysis.
2.2 | Muscle processing
Muscles were fractionated into myofibrillar and soluble frac-
tions according to Camera et al,.10 Briefly, samples were 
pulverized under liquid nitrogen using a mortar and pestle. 
One-hundred milligrams of the tissue powder was homog-
enized on ice in 10 volumes of 1% Triton X-100, 50 mM Tris 
pH 7.4 including phosphatase inhibitor and complete pro-
tease inhibitor cocktails (Roche, Indianapolis, USA) using a 
PolyTron homogenizer. Samples were incubated on ice for 
15 minutes, then centrifuged at 1000 g, 4°C, for 5 minutes. 
Supernatants containing soluble proteins were decanted and 
stored on ice, and the myofibrillar pellet was resuspended 
in 0.5  mL of homogenization buffer, then centrifuged at 
1000 g, 4°C for 5 minutes. The washed myofibrillar pellet 
was solubilized in 10 volumes of 7 M urea, 2 M thiourea, 4% 
CHAPS, 30mM Tris, pH 8.5, and cleared by centrifugation 
at 12 000 g, 4°C, 45 minutes. Protein concentrations of each 
myofibrillar and soluble protein sample were measured using 
the Bradford assay (Sigma-Aldrich, Poole, Dorset, UK).
2.3 | Top-down proteomic analysis of 
myofibrillar proteins using 2DGE and MALDI 
mass spectrometry
Homogenates of the myofibrillar fraction were prepared 
for 2DGE as described previously.2 Gels were produced in 
batches of eight, comprising individual gels for each left and 
right EDL from one animal in each group (0, 10, 20, and 30 
days). An aliquot of each supernatant was precipitated in 5 
volumes of acetone at −20°C for 1  hour then resuspended 
in 7 M urea, 2 M Thiourea, 2% (w/v) CHAPS, 20 mM dithi-
othreitol, 0.5% (v/v), and ampholytes (pH 3-11). Samples, 
containing 250 µg protein, were loaded on to 13 cm pH 3-11 
nonlinear IPG strips (GE Healthcare, Chalfont St Giles, UK) 
and resolved using an “active rehydration” and isoelectric 
focusing protocol comprising: 150 Vh at 30  V, 300 Vh at 
60  V, 500 Vh at 500  V, 1000 Vh at 1000  V, and 48 000 
Vh at 8000 V; conducted on an IPGPhor II (GE Healthcare) 
at 20°C, maximum 50 mA per strip. IPG strips were equili-
brated in 50 mM Tris-HCl pH 8.8, containing 6 M urea, 30% 
(v/v) glycerol, 70 mM SDS, and a trace of bromophenol blue. 
DTT (65 mM) was present as a reducing agent in the first 
equilibration and iodoacetamide (135  mM) in the second. 
Proteins were electrophoresed from the IPG strip through 
16 cm linear 12% polyacrylamide gels at 20°C; at a constant 
current of 15  mA per gel for 30  minutes, then 30  mA per 
gel until the tracking dye reached the bottom edge of the 
gel. Gels were washed and stained with colloidal Coomassie 
blue (Bio-Safe; BioRad, Hercules, CA, USA) according to 
the manufacturer's instructions. Digitized images (8-bit gray 
scale, 300 dpi) of stained gels were saved as tagged-image 
file format (tiff) files.
2.4 | Myofibrillar protein 
abundance analysis
Image analysis (Samespots, v3.0, Nonlinear Dynamics, 
Newcastle, UK) was performed on the 24 individual 2DGE 
images, representing myofibrillar proteins from the EDL 
muscles of the stimulated and non-stimulated limb from n = 3 
animals at each of the four experimental time points (0, 10, 
20 and 30 days). Prominent spots were manually identified 
to avoiding including gel artifacts and the gel images were 
warped to align the spot positions to a common reference gel. 
The resulting spot outlines were applied to each parent image 
and manually verified, consistent with our previous work.2
2.5 | Identification of myofibrillar proteins 
using peptide mass fingerprinting
Gel spots were cut and processed using an Xcise robot 
(Proteome Systems, North Ryde, Australia) as described pre-
viously.3 Gel plugs, destained in three changes of 25  mM 
ammonium bicarbonate in 50% acetonitrile were dehydrated 
before being incubated with 35 µL of 1.25  mg/mL porcine 
trypsin (Promega, Madison, WI, USA) in 50 mM ammonium 
bicarbonate. Peptide solutions were de-salted and concen-
trated (Zip-tips; Millipore, Billercia, MA, USA) before being 
mixed with matrix (3.5 µg α-cyano-4-hydroxcinnamic acid in 
50:50 acetonitrile and 0.1% trifluoroacetic acid) and spotted 
on to 384-well stainless-steel target plates. A calibration mix 
(Laserbio Labs, Sophia Antipolis, France) consisting of angio-
tensin II (m/z 1046.2), angiotensin I (m/z 1296.5), neurotensin 
(m/z 1672.9), ACTH fragment {1-17} (m/z 2093.5), and ACTH 
fragment {18-39} (m/z 2465.19) was mixed 1:1 with matrix so-
lution and spotted (0.5 µL) between every four sample-wells. 
Peptide mass spectra were recorded using a matrix-assisted 
laser desorption ionization tandem time of flight (MALDI-
TOF/TOF) mass spectrometer (Axima TOF2; Shimadzu 
Biotech, Manchester, UK) in positive reflectron mode over 
a mass/charge (m/z) range of 900-3000. Data were smoothed 
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(Gaussian, two channel peak width), baseline subtracted (100 
channel peak width), and an adaptive (8.0ˆ) threshold applied. 
Peptide mass lists (restricted to 20 peptides over 900-3000 m/z) 
were produced using the peak selection tool of the instrument's 
Launchpad software (Version 2.8.4) and searched against the 
UniProt database restricted to “Rattus” using a locally imple-
mented MASCOT server (v.2.2.03; www.matri xscie nce.com). 
The enzyme specificity was set as trypsin allowing one missed 
cleavage, carbamidomethyl modification of cysteine (fixed), 
oxidation of methionine (variable), and an m/z error of ±0.3 Da.
Mass spectrometry data were recorded from every gel spot in 
every muscle sample (ie, left (stimulated) and right (non-stim-
ulated) EDL from 0, 10, 20, and 30 days groups, n = 3 rats per 
group). Raw mass spectra were exported in mzXML format and 
mMass software (Version 5.5.0, http://www.mmass.org) was 
used to extract intensity data for the monoisotopic peak (m0), 
m1, and m2 mass isotopomers of five selected peptides for each 
protein/ proteoform, as previously described.18
2.6 | Bottom-up analysis of soluble proteins 
using LC-MS/MS label-free quantitation
Soluble proteins in lysis buffer at a concentration of 5 μg/μL 
were processed for mass spectrometry by in-solution diges-
tion according to the filter aided sample preparation (FASP) 
method.19 Lysates containing 200 μg protein were precipitated 
in five volumes acetone at −20°C for 1 hour and the protein 
pellets were resuspended in 200 μL of UA buffer (8 M urea, 
100  mM tris, pH 8.5). Samples were incubated at 37°C for 
15  minutes in UA buffer with 100  mM dithiothreitol (DTT) 
followed by 20 minutes at 4°C in UA buffer containing 50 mM 
iodoacetamide (protected from light). Samples were washed 
twice with 100 μl UA buffer and transferred to 50 mM ammo-
nium hydrogen bicarbonate (Ambic). Sequencing grade trypsin 
(Promega; Madison, WI, USA) in 50 mM Ambic was added 
at an enzyme to protein ratio of 1:50 and the samples were di-
gested overnight at 37°C. To terminate digestion, peptides were 
collected in 50 mM Ambic and trifluoracetic acid (TFA) was 
added to a final concentration of 0.2% (v/v). Aliquots, contain-
ing 4 µg peptides, were desalted using C18 Zip-tips (Millipore, 
Billercia, MA, USA) and eluted in 50:50 of acetonitrile and 
0.1% TFA. Peptide solutions were dried by vacuum centrifuga-
tion for 25 minutes at 60°C and peptides were resuspended in 
0.1% formic acid (FA) spiked with 10 fmol/μL yeast ADH1 
(Waters Corp.) in preparation for LC-MS/MS analysis.16
2.7 | Liquid chromatography-mass 
spectrometry
Label-free liquid chromatography-mass spectrometry analysis 
was performed using nanoscale reverse-phase ultra-performance 
liquid chromatography (UPLC; Nano Acquity; Waters) and 
online electrospray ionization quadrupole–time-of-flight mass 
spectrometry (ESI-Q-TOF; QTOF Premier; Waters). Samples 
(1 μg tryptic peptides) were loaded in aqueous 0.1% (v/v) FA 
via a Symmetry C18 5 µm, 2 cm, 180 µm trap column (Waters). 
Separation was conducted at 35°C via a BEH C18 1.7 µm, 25 cm, 
75  µm analytical reverse-phase column (Waters). Peptides 
were eluted using a gradient that rose to 37.5% acetonitrile 
0.1% (v/v) FA over 90 minutes at a flow rate of 300 nL/min. 
For all measurements, the mass spectrometer was oper-
ated in positive electrospray ionization mode at a resolution 
of >10,000 full width at half maximum. Before analysis, the 
time-of-flight analyzer was calibrated using fragment ions of 
[Glu-1]-fibrinopeptide B from m/z 50-1990. Mass spectra (MS) 
for liquid chromatography-mass spectrometry profiling were 
recorded between 350 and 1600 m/z using mass spectrometry 
survey scans of 0.45-seconds duration with an inter scan delay 
of 0.05 seconds. In addition, equivalent data-dependent tandem 
mass spectrometry (MS/MS) spectra were collected from each 
0 days (control) sample. MS/MS spectra of collision-induced 
dissociation fragment ions were recorded for the five most 
abundant precursor ions of charge 2+ or 3+ detected in the sur-
vey scan. Precursor fragmentation was achieved by collision-
induced dissociation at an elevated (20-40 eV) collision energy 
over a duration of 0.15 s per parent ion with an inter scan delay 
of 0.05 s over 50-2000 m/z. Acquisition was switched from MS 
to MS/MS when the base peak intensity exceeded a threshold 
of 30 counts/s, and returned to the MS mode when the total ion 
chromatogram (TIC) in the MS/MS channel exceeded 10 000 
counts or when 1.0 s (5 scans) were acquired. To avoid repeated 
selection of peptides for MS/MS, the program used a 30-sec-
onds dynamic exclusion window.
Progenesis QI for proteomics (Nonlinear Dynamics, 
Newcastle, UK) was used to perform label-free quantitation 
(LFQ) consistent with our previous work.20-23 Prominent ion 
features (>600 per chromatogram) were used as vectors to 
align each data set to a reference chromatogram. An analysis 
window of 15-105 minutes and 350-1500 m/z was selected. 
Log-transformed MS data were normalized by inter-sample 
abundance ratio, and differences in relative protein abun-
dance were investigated using nonconflicting peptides only.
MS/MS spectra were exported in Mascot generic format 
and searched against the Swiss-Prot database restricted to 
Rattus (8,071 sequences) using a locally implemented Mascot 
server (v.2.2.03; www.matri xscie nce.com). Enzyme specific-
ity was trypsin, which allowed one missed cleavage, carba-
midomethyl modification of cysteine (fixed), deamination of 
asparagine and glutamine (variable), oxidation of methionine 
(variable), and an m/z error of ± 0.3 Da. Mascot output (xml 
format), restricted to nonhomologous protein identifications, 
was recombined with MS profile data, and peptides modified 
by deamination or oxidation were removed before quantita-
tive analysis.
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Mass isotopomer abundance data were extracted 
from MS only spectra using Progenesis QI (Nonlinear 
Dynamics). Peak picking was performed on ion features 
with +2, or +3 charge states within an analysis window of 
15-105 minutes and 350-1500 m/z. The abundance of the 
monoisotopic peak (m0), m1, m2, and m3 mass isotopomers 
were collected over the entire chromatographic peak for 
each nonconflicting peptide that was used for LFQ, as pre-
viously described.10
2.8 | Calculation of individual protein 
synthesis rates
The FSR of each protein was calculated in stimulated and 
contra-lateral non-stimulated (control) muscles.
Precursor enrichment was back calculated from peptide 
mass isotopomer data according to.18 Briefly the enriched 
molar fraction of each mass isotopomer was calculated by 
subtracting the molar fraction of the unlabeled control pep-
tide from the equivalent 2H2O-labeled peptide, and the en-
richment ratio between m2 and m1 mass isotopomers was 
used to calculate precursor enrichment (p) using:
Where EM1 is the enriched molar fraction of m1 and 
EM2 is the enriched molar fraction of m2 and n is the num-
ber of H-D exchange sites counted by referencing the pep-
tide amino acid sequence against standard tables.24 The 
median precursor enrichment of each animal was derived 
from peptides belonging to serum albumin (ALBU) and 
this value of p was used in 5 to calculate the FSR of indi-
vidual peptides.
Protein FSR were calculated from the incorporation of 
deuterium into newly synthesized protein, which results in 
a decrease in the molar fraction (fm0) of the monoisotopic 
(m0) peak.
The rate constant (k) for the decay of fm0 was calculated 
using semi-log plots to fit a linear model (y = k · x + c) to the 
change (Δ) in log-transformed fm0 data across 0, 10, 20, and 
30 days, as a function of time.
Data were filtered to exclude peptides with a goodness of 
fit, R-squared (R2), to the linear model of <0.85. In addition, 
the rate constant (k) for the decay of fm0 was also calculated 
as a first-order exponential spanning from the beginning (t) 
to end (t′) of each 10-day labeling period, for example, 0-10, 
10-20 days, etc, using Equation (4).
Regardless of whether Equations (3) or (4) is used, the 
calculation of FSR from k depends on the number (n) of 
2H exchangeable H–C bonds, which was calculated by ref-
erencing each peptide sequence against standard tables.24 
Peptide FSR was derived by dividing k by the molar per-
cent enrichment of deuterium in the precursor (p) pool and 
the total number (n) of 2H exchangeable H–C bonds in each 
peptide.
Protein FSR was reported as the median value of peptides 
unique to each protein. Decimal values were multiplied by 
100 to give FSR in %/d.
2.9 | Calculation of absolute muscle 
protein data
Relative data (eg, density of 2DGE spots, LFQ of soluble 
peptides, and protein specific FSR) were converted to ab-
solute values for each muscle. Total protein extracted from 
each muscle fraction was calculated.
The yield of protein extracted per mg of muscle powder 
was calculated from the concentration of myofibrillar or sol-
uble protein (PC; mg/mL) measured by protein assay, multi-
plied by the volume (mL) of homogenate (HV) and divided 
by the mass (mg) of aliquoted muscle powder (MP). The 
yield of soluble and myofibrillar proteins per mg of muscle 
powder was multiplied by muscle wet weight (WW) to calcu-
late the protein content (mg).
The normalized relative abundance (ABDrel) of proteins 
in the soluble fraction was calculated by LFQ against 50 
fmol yeast alcohol dehydrogenase (ADH1_Yeast) that was 
spiked into each sample after tryptic digestion. Relative 
abundance ABDrel data in fmol/ μg peptide digest were 
multiplied by total protein content (μg) of the soluble frac-
tion to calculate absolute protein abundance (ABDabs) in 
pmol.
(1)p=
((
EM2
EM1
)/
(n−1)
2
)
⋅100
(2)fm0=
m0
m0+m1+m2+m3
(3)k= Δ(− ln(fm0))−c
Δ (time)
(4)k= 1
t� − t
⋅− ln
(
fm0t
fm0t�
)
(5)FSR= k
(n ⋅p)
(6)Protein content =
(
PC ⋅ HV
MP
)
⋅ WW
(7)ABDabs=
Protein content ⋅ABDrel
1000
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Mole abundance data (ABDabs) were converted to abso-
lute (μg) values using:
Where MW is the protein molecular weight (kDa) spec-
ified in the UniProt database and ABDabs is the mole abun-
dance of the protein from Equation (7) expressed in fmol.
Absolute abundance (ABD) of proteins in the myofibrillar 
fraction was calculated by converting spot density (AU) into 
μg values.25
The protein load (250 μg) of each gel was divided by the 
sum density of all spots to give a conversion factor for each 
gel. Individual spot densities were multiplied by the gel con-
version factor to give abundance values/μg protein loaded on 
each gel. Spot abundance data were multiplied by the total 
content of myofibrillar protein to derive the absolute abun-
dance (μg) of each protein in each muscle.
The absolute synthesis rate (ASR) of individual proteins 
was calculated by multiplying protein abundance (pg) by the 
decimal FSR.
The rate of change in protein abundance was calculated by 
converting the difference in abundance between stimulated 
and contra-lateral control muscle into abundance rate (ABR) 
change from the beginning (t) to end (t’) of each labeling 
period.
Absolute degradation rate (ADR) was calculated as the 
difference between ASR and the rate of change in abundance.
2.10 | Statistical analysis
Unless stated otherwise, data are presented as mean ± stand-
ard deviation (SD) and statistical analyses were conducted in 
R (version 3.6.2). One factor analysis of variance (ANOVA) 
was used to test the consistency of data in control non-stimu-
lated muscle over the duration (0–30 days) of the experimen-
tal period. At each time point, differences between stimulated 
and contra-lateral control were investigated using Student's 
paired t tests. Significance data were controlled for multiple 
testing using the Benjamini-Hochberg (BH) procedure.
3 |  RESULTS
Surgical implantation of stimulators in preparation for 
unilateral CLFS in vivo did not significantly affect either 
the wet weight (Figure  1A) or protein abundance profile 
(Figure 1B) of EDL muscle (Day 0 time point). There was 
also no significant change in the wet weight or protein pro-
file (Figure 1A and 1C, respectively), of the non-stimulated 
control (Ctrl) EDL at the end of the experimental period. 
In response to CLFS, the wet weight (92 ± 8 mg) of stimu-
lated (Stim) EDL was 50% less (P  <  .05) than the con-
tralateral Ctrl (185 ± 16 mg) after the 30-day intervention 
(Figure 1A).
“Top-down” analysis of myofibrillar proteins was per-
formed to investigate the multiple proteoforms of myofibril-
lar proteins. 2DGE is optimized for this purpose and resolved 
43 protein spots in each Stim and Ctrl EDL (total of 24 sam-
ples, n = 3 biological replicates at 0, 10, 20, and 30 days ex-
perimental time points). MS were recorded only from in-gel 
digests of each spot present in every biological sample (ap-
proximately 1000 gel spots analyzed). After filtering based 
on quality control criteria, a total of 30 spots had complete 
data from five peptides per protein present in all samples. 
In addition, a further eight spots were detected by the same 
criterion only in Stim samples after > 20 days CLFS. The 
total number of nonredundant protein identifications from 
top-down analysis was 23, and 10 proteins were resolved to 
multiple proteoforms. Supporting Information illustrates the 
gel position of the 38 spots that satisfied the requirements 
for protein synthesis calculations and provides the identity 
of each gel spot. “Bottom-up” analysis of soluble proteins 
by LC-MS/MS yielded a list of 46 proteins that had at least 
one protein-specific peptide with a good fit (R2 > 0.85) to 
the nonlinear model and were detected in all (n = 24) Ctrl 
and Stim samples. The majority of soluble proteins identified 
were enzymes of either mitochondrial/oxidative metabolism 
or glycolysis/anaerobic metabolism.
At the onset of the experiment there were no significant 
differences in protein abundance between sham-operated and 
Ctrl muscle, the Pearson correlation coefficient (r) for pro-
tein abundance was r =  .9899 (Figure 1B) and the median 
coefficient of variation was 20.2%. Protein abundance pro-
files were consistent in Ctrl EDL throughout the experiment. 
The Pearson correlation coefficient for protein abundance 
between Ctrl muscle at day 0 and day 30 of the experiment 
was r = .9997 (Figure 1C), the median and interquartile range 
in coefficient of variation was 2.45% (IQR: 0.5%-2.66%) 
demonstrating high levels of reproducibility for our analysis 
in Ctrl unstimulated EDL.
Statistically significant (P  <  .05 BH-corrected) differ-
ences in protein abundance were detected in Stim EDL 
and became more numerous from 20 to 30-days time 
points (Figure  1D-F). The changes in myofibrillar protein 
(8)ABD=MW ⋅ ABDabs
(9)ABD=
((
Gel protein load
Total spot density
)
⋅ Spot density
)
⋅ 4
(10)ASR=ABD ⋅ FSR
(11)ABR= 1
t� − t
⋅
(
ABDt� −ABDt
)
(12)ADR=ASR−ABR
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abundance were consistent with a shift toward a slower phe-
notype in Stim EDL. The fast isoform of troponin T (TNNT3) 
was resolved as three separate proteoforms (spots 25, 26, 28), 
each of which decreased after 30 days CLFS. The slow iso-
forms of myosin regulatory (MLRV) and essential (MYL3) 
light chains were absent in Ctrl EDL and first emerged after 
10 and 20 days CLFS, respectively. In addition, new proteo-
forms of TNNT1 (spots 33, 34) were detected after 20 days 
CLFS. Table 1 provides a summary of new proteoforms that 
emerged in Stim EDL.
Changes in the soluble fraction agreed with the shift in 
myofibrillar proteoforms indicative of a more oxidative, 
slow-twitch phenotype. After 10 days CLFS, the total abun-
dance of ATP synthase-alpha (ATPA) increased (1.46-fold, 
P =  .0121, FDR = 46%) and the so-called brain isoform 
of glycogen phosphorylase (PYGB) decreased (1.43-fold, 
P = .0048, FDR = 37%). After 20 days CLFS (Figure 1E), 
there were further increases in the abundance of enzymes 
involved in aerobic metabolism. The abundance of ATP syn-
thase-beta (ATPB) became 1.88-fold greater (P = .011 BH-
corrected) in Stim (82.36 μg) compared to Ctrl (43.66 μg) 
and cytochrome C oxidase subunit 7A2 (CX7A2) abun-
dance increased from 6.05  μg to 8.9  μg (P  =  .0034 BH-
corrected). These changes cooccurred alongside significant 
decreases in the abundance of the calcium handling protein, 
parvalbumin (PRVA), and enzymes involved in glycolytic 
metabolism, including beta-enolase, (ENOB), glyceralde-
hyde-3-phosphate dehydrogenase (G3P), and the muscle 
isoform of lactate dehydrogenase (LDHA). EDL muscle 
exposed to 30 days CLFS (Figure 1F) exhibited further de-
creases in the abundance of glycolytic enzymes, including 
triosephosphate isomerase (TPIS) and phosphofructoki-
nase (PFKAM), which were 4.68-fold and 2.14-fold less 
(P <  .05 BH-corrected) abundant in Stim EDL. Whereas 
alpha- and beta- subunits of ATP synthase were 3.69- and 
1.98-fold more (P <  .05 BH-corrected) abundant in Stim 
EDL (Figure 1F).
The FSR among all 76 proteins measured across 0 to 30 
days time points (Equation 3) in n = 3 biological replicates 
averaged 4.97 ± 3.9%/d in Ctrl and 5.18 ± 4.18%/d in Stim 
muscle. Protein-specific FSR ranged from 0.55 ± 0.15%/d 
(Plectin, PLEC_2) to 17.02 ± 5.01%/d (carbonic anhydrase 
F I G U R E  1  Temporal adaptation of EDL to chronic low-frequency stimulation in vivo. A, Wet weight (mg) of extensor digitorum longus 
(EDL) stimulated (Stim) at 10 Hz and contralateral non-stimulated control (Ctrl). Data are presented as mean ± SD from independent groups of 
n = 3 rats at each time point *P < .05 statistically significant difference between Stim and Ctrl assessed using paired t-tests at each experimental 
time point. B, Pearson correlation coefficient (r) in total abundance (ng) of n = 76 proteins quantified in EDL of n = 3 sham-operated and 
contralateral Ctrl limbs representing the beginning (day 0) of the experimental period. C, Correlation (r) in protein abundances (n = 76) quantified 
in Ctrl EDL at the beginning (day 0) and end (day 30) of the experimental period (n = 3, biological replicates). Fold differences (Diff) in protein 
abundance between Stim and Ctrl EDL after 10 days (D), 20 days (E), or 30 days (F) of unilateral chronic low-frequency stimulation (CLFS). 
Proteins that changed significantly (P < .05, BH-corrected) in Stim muscle are colored and labeled by their UniProt identifier
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3, CAH3_29). The distribution of synthesis data were strik-
ingly different when reported in absolute (ng/d) units and 
linear regression found that FSR explained <15% of the dif-
ference ASR (Figure 2A). The ASR of proteins in Ctrl mus-
cle spanned three orders of magnitude from 0.34 ± 0.19 ng/d 
(four-and-a-half LIM domains protein 1; FHL1) to 
292.78 ± 20.07 μg/d (tropomyosin alpha-4; TPM4). In keep-
ing with the unchanging abundance of proteins in Ctrl mus-
cle (Figure 1C), the ASR of proteins in non-stimulated EDL 
did not differ over the 30-d experimental period. The ADR 
of each protein was calculated from differences between the 
rate of change in protein abundance (absolute abundance 
rate; ABR) and the absolute rate of protein synthesis during 
the experimental period. Accordingly, there was no differ-
ence in protein ADR in Ctrl muscle during the 30-d experi-
mental period. Proteo-ADPT data for each protein studied is 
presented in Table 2.
Figure  2 summarises the numbers of proteins that ex-
hibited significant (P <  .05 BH-corrected) differences over 
the entire 30-d CLFS intervention. Volcano plots of the 
fold-change and significance of individual protein FSR, 
ASR, and ADR are provided in Figure  2C-E, respectively. 
After 30 days CLFS there were 34 significant (P < .05 BH-
corrected) differences in protein-specific FSR (Figure  2C). 
The FSR of glycolytic enzymes such as TPIS was less in Stim 
(0.9 ± 0.02%/d) than Ctrl (2.05 ± 0.04%/d), whereas mito-
chondrial proteins were common among the proteins that had 
significantly greater FSR in Stim EDL. A similar pattern was 
evident when the absolute synthesis rate (ASR; ng/d) of in-
dividual proteins was compared (Figure 2D). There were 23 
significant (P < .05 BH-corrected) differences in protein-spe-
cific ASR. The ASR of TPIS in Stim (375.5 ± 18.2 ng/d) was 
3.2-fold less than Ctrl (1187.2 ± 42.2 ng/d), whereas the ASR 
of ATP synthase alpha (ATPA) was 6294  ±  958.6  ng/d in 
Stim and 1181 ± 226.9 ng/d in Ctrl. Twelve proteins exhib-
ited greater (P < .05 BH-corrected) degradation in Stim than 
Ctrl muscle after 30 days CLFS (Figure 2E). For example, the 
ADR of plectin (PLEC_2) was 24 807 ± 856 ng/d in Stim and 
5584 ± 1706 ng/d in Ctrl muscle.
Six proteins: carbonic anhydrase 3 (CAH3), calsequestrin 
(CASQ1), heat shock protein 20 (HSPB6), mitochondrial 
creatine kinase (KCRS_19), fast troponin T (TNNT3_25), 
and triosephosphate isomerase (TPIS) exhibited significant 
differences in FSR, ASR, and ADR (Figure  2B). CASQ1, 
HSPB6, and KCRS_19 exhibited greater FSR, ASR, and 
ADR in Stim muscle, indicating enhanced turnover of these 
proteins in addition to the significant gains in the abundance 
of these proteins reported in Figure  1F. In contrast, TPIS 
exhibited lesser FSR and ASR but greater ADR in Stim, 
indicating that changes in both synthesis and degradation 
contributed to the change in TPIS abundance.
Figure  2F shows the percent contribution that degrada-
tion made to the significant changes in protein abundance. 
Overall, degradation contributed 49% to the changes in 
T A B L E  1  Emergent proteins in CLFS muscle
Identifier
20 days ABD (μg) 20-30 days 20-30 days 20-30 days 20-30 days
30 days ABD (μg) FSR (%/d) ABR (ng/d) ASR (ng/d) ADR (ng/d)
CRYAB_35* 18.88 ± 1.89 2.47 ± 0.43 85.51 ± 372.03 480 ± 138 394 ± 238
19.73 ± 5.23
KCRS_32* 37.96 ± 5.23 4.9 ± 0.57 174.22 ± 3,243.97 1,898 ± 145 1724 ± 3,219
39.71 ± 19.47
MLRV_31* 44.24 ± 9.43 1.59 ± 0.56 36.88 ± 782.42 712.15 ± 307.97 675.27 ± 738.01
44.60 ± 5.20
MYL3_36 47.03 ± 15.05 3.87 ± 0.85 780.11 ± 1,022.84 1,938.64 ± 660,61 1,158.54 ± 1,102.79
54.83 ± 23.03
MYL3_37 29.68 ± 3.32 4.21 ± 0.33 578.82 ± 624.54 1,369.02 ± 213.76 790.21 ± 622.45
35.47 ± 7.05
MYL3_38 70.88 ± 11.13 2.13 ± 0.28 1,388.91 ± 2,097.22 1,662.47 ± 283.74 273.56 ± 2,204.61
84.77 ± 11.03
TNNT1_33* 30.72 ± 14.42 2.66 ± 0.23 2,948.85 ± 2,439.33 1,211.08 ± 184.20 -1737.78 ± 2,595.90
60.21 ± 10.84
TNNT1_34* 22.16 ± 1.30 3.61 ± 0.34 187.26 ± 299.58 831.54 ± 59.44 644.28 ± 253.55
24.03 ± 3.36
Note: Data are presented for proteins that emerged in EDL after >20 days CLFS. Identifier represents the UniProt identifier and 2DGE spot number of each 
proteoform, *represents proteoforms that may also have been detected in some replicates after 10 days CLFS. Total abundance (ABD) of each proteoform after 20 or 
30 days CLFS is presented (μg). Fractional synthesis rate (FSR, %/d) was calculated between 20 days and 30 CLFS using Equation (4). The absolute rate of abundance 
change (ABR), synthesis (ASR) and degradation (ADR) are presented in ng/d.
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protein abundance calculated over the entire 30-day experi-
mental period. There was a broad distribution in the relative 
contributions of synthesis and degradation to the significant 
changes in protein abundance. The abundance of phosphof-
ructokinase (PFKAM) decreased at a rate of 754.95 ng/d from 
23.76 ± 3.79 μg per muscle in Ctrl to 1.1 ± 0.38 μg per muscle 
in Stim during the course of the 30-day experiment (Figure 2G). 
The average difference in ASR between Stim (1023  ng/d) 
and Ctrl (2219 ng/d) was 1196 ng/d. Whereas the difference 
in ADR between Stim (1778 ng/d) and Ctrl (2219 ng/d) was 
441 ng/d. Therefore, the 1196 ng/d lesser ASR combined with 
the 441 ng/d lesser in ADR in Stim accounts for the 755 ng/d 
change in PFKAM abundance. Proteo-ADPT data for each of 
the 76 proteins investigated are provided in Table 2.
F I G U R E  2  Dynamic responses of EDL muscle from 0-30 days of chronic -low-frequency stimulation. A, Distribution of individual protein 
fractional (FSR) and absolute (ASR) synthesis rates in Ctrl muscle calculated from data collected at 0, 10, 20, and 30 days experimental time 
points using Equation (3). B, Venn diagram illustrating the numbers of proteins that shared significant (P < .05 BH-corrected) differences in 
fractional synthesis rate (FSR), absolute synthesis rate (ASR) and absolute degradation rate (ADR). Volcano plots illustrating fold differences 
(Diff) in protein FSR (C), ASR (D), and ADR (E) in Stim compared to Ctrl EDL after 30-d CLFS. Proteins that differed significantly (P < .05, 
BH-corrected) in Stim muscle are colored and labeled by their UniProt identifier. F, Percent contribution of degradation to significant (P < .05 BH-
corrected) changes in protein abundance. Protein abundance change (%) represents the rate (ng/d) of change in abundance expressed as a percentage 
of the average protein abundance during the 30-d experimental period. (G and H) Box plots reporting total protein abundance (ABD, ng), rate of 
change in abundance (ABR, ng/d), absolute synthesis rate (ASR, ng/d), absolute degradation rate (ADR, ng/d), and FSR (%/d) for (G) fast skeletal 
muscle myosin regulatory light chain (MLRS) proteoform 11 and (H) phosphofructokinase (PFKAM)
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T A B L E  2  Proteo-ADPT data 0-30 days CLFS
Identifier Group ABD (μg) FSR (%/d) ASR (ng/d) ABR (ng/d) ADR (ng/d)
AATC Ctrl 43.592 ± 3.384 0.88 ± 0.07 383.68 ± 3.32 0 ± 0 383.68 ± 3.32
Stim 50.003 ± 4.554 1.67 ± 0.11 784.84 ± 119.29 213.68 ± 42.39 571.16 ± 81.89
AATM Ctrl 34.221 ± 4.305 0.87 ± 0.04 298.96 ± 38.68 0 ± 0 298.96 ± 38.68
Stim 55.58 ± 5.454 2.3 ± 0.21 1028.94 ± 54.35 711.95 ± 230.48 317 ± 281.59
ACADL Ctrl 8.162 ± 3.68 2.61 ± 0.04 212.68 ± 95.31 0 ± 0 212.68 ± 95.31
Stim 25.567 ± 3.297 4.02 ± 0.16 679.15 ± 87.14 580.15 ± 198.98 99.01 ± 205.11
ACON Ctrl 78.282 ± 10.375 5.07 ± 0.04 3967.9 ± 554.63 0 ± 0 3967.9 ± 554.63
Stim 89.169 ± 11.258 7.28 ± 0.11 6100.55 ± 830.82 362.9 ± 257.26 5737.66 ± 841.53
ACTA Ctrl 61.161 ± 11.523 1.01 ± 0.01 617.14 ± 112.47 0 ± 0 617.14 ± 112.47
Stim 58.469 ± 6.794 1.53 ± 0.27 901.62 ± 52.84 −89.74 ± 160.83 991.36 ± 139.02
ACTN1_1 Ctrl 405.496 ± 30.172 4.26 ± 0.17 17314.46 ± 1948.02 0 ± 0 17314.46 ± 1948.02
Stim 164.731 ± 35.286 5.07 ± 0.07 14445.82 ± 1574.07 −8025.48 ± 870.36 22471.3 ± 1721.73
ACTS_5 Ctrl 15168.203 ± 1309.041 1.48 ± 0.18 222450.22 ± 11174.94 0 ± 0 222450.22 ± 11174.94
Stim 6607.98 ± 2706.648 1.63 ± 0.2 177259.56 ± 34551.35 −285340.78 ± 47017.47 462600.34 ± 31187.12
ALBU Ctrl 243.555 ± 13.654 7.1 ± 0.09 17292.04 ± 1143.14 0 ± 0 17292.04 ± 1143.14
Stim 247.663 ± 17.125 7.26 ± 0.03 17831.57 ± 1002.56 136.95 ± 314.03 17694.62 ± 938.63
ALDOA Ctrl 105.533 ± 8.929 8.57 ± 0.07 9041.99 ± 718.92 0 ± 0 9041.99 ± 718.92
Stim 107.591 ± 13.154 8.43 ± 0.33 8966.08 ± 352.68 68.61 ± 504.91 8897.48 ± 486.85
ALDR Ctrl 14.857 ± 5.685 8.31 ± 0.48 1252.86 ± 547.75 0 ± 0 1252.86 ± 547.75
Stim 14.576 ± 2.829 8.35 ± 0.19 1233.66 ± 372.77 −9.35 ± 121.2 1243.01 ± 477.47
ANXA4_20 Ctrl 96.002 ± 6.515 1.21 ± 0.09 1167.16 ± 167.96 0 ± 0 1167.16 ± 167.96
Stim 44.042 ± 4.98 1.27 ± 0.08 891.6 ± 124.51 −1731.99 ± 128.43 2623.59 ± 223.16
AT2A2 Ctrl 291.584 ± 27.49 1.39 ± 0.35 4022.31 ± 820.52 0 ± 0 4022.31 ± 820.52
Stim 273.248 ± 28.487 1.52 ± 0.34 4233.8 ± 632.36 −611.17 ± 1132.4 4844.98 ± 1549.32
ATPA Ctrl 84.809 ± 29.446 1.44 ± 0.23 1181.01 ± 226.93 0 ± 0 1181.01 ± 226.93
Stim 312.892 ± 28.477 3.16 ± 0.03 6293.98 ± 958.65 7602.77 ± 332.85 −1308.79 ± 1042.17
ATPA_15 Ctrl 208.838 ± 34.349 2.66 ± 0.14 5580.88 ± 1207.51 0 ± 0 5580.88 ± 1207.51
Stim 108.746 ± 30.784 3.13 ± 0.05 4957.02 ± 922.48 −3336.41 ± 383.08 8293.43 ± 1108.25
ATPB Ctrl 79.212 ± 17.137 8.93 ± 0.49 7051.56 ± 1408.75 0 ± 0 7051.56 ± 1408.75
Stim 156.501 ± 12.825 10.04 ± 0.72 11845.89 ± 1622.98 2576.27 ± 603.41 9269.62 ± 1567.04
ATPB_4 Ctrl 1706.319 ± 145.531 9.07 ± 0.03 154731.89 ± 12664.85 0 ± 0 154731.89 ± 12664.85
Stim 1739.905 ± 2094.648 11.18 ± 0.1 193243.78 ± 116927.47 1119.53 ± 71444.82 192124.25 ± 47124.97
ATPO Ctrl 15.344 ± 3.419 6.7 ± 0.06 1027.14 ± 223.81 0 ± 0 1027.14 ± 223.81
Stim 36.871 ± 1.609 8.32 ± 0.03 2173.76 ± 199.42 717.59 ± 88.62 1456.18 ± 270.06
CAH3 Ctrl 21.315 ± 1.457 14.55 ± 0.28 3101.48 ± 228.51 0 ± 0 3101.48 ± 228.51
Stim 70.147 ± 12.132 17.02 ± 0.17 7792.69 ± 1141.01 1627.74 ± 398.03 6164.95 ± 757.58
CAH3_29 Ctrl 852.223 ± 77.549 17.15 ± 0.14 146241.07 ± 14426.05 0 ± 0 146241.07 ± 14426.05
Stim 759.728 ± 874.42 19.5 ± 0.32 157847.21 ± 83637.41 −3083.16 ± 30795.48 160930.38 ± 53221.33
CAH3_30 Ctrl 980.578 ± 82.811 20.43 ± 0.26 200225.26 ± 14453.65 0 ± 0 200225.26 ± 14453.65
Stim 998.806 ± 1254.078 22.15 ± 0.06 219412.19 ± 133930.1 607.62 ± 43600.38 218804.57 ± 90655.57
CASQ1 Ctrl 0.205 ± 0.023 9.47 ± 0.18 19.43 ± 2.36 0 ± 0 19.43 ± 2.36
Stim 0.71 ± 0.052 11.16 ± 0.01 51.05 ± 1.92 16.83 ± 2.41 34.22 ± 1.26
CX7A2 Ctrl 6.084 ± 0.287 7.27 ± 0.04 442.56 ± 21.29 0 ± 0 442.56 ± 21.29
Stim 6.367 ± 0.946 7.33 ± 0.36 457.11 ± 53.43 9.42 ± 36.85 447.69 ± 32.45
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Identifier Group ABD (μg) FSR (%/d) ASR (ng/d) ABR (ng/d) ADR (ng/d)
DESM_3 Ctrl 709.712 ± 59.405 4.44 ± 0.27 31389.53 ± 928.18 0 ± 0 31389.53 ± 928.18
Stim 322.224 ± 134.632 4.55 ± 0.24 23533.83 ± 4603.63 −12916.29 ± 3088.12 36450.12 ± 1941.28
ENOB Ctrl 12.279 ± 2.435 8.5 ± 0.46 1040.21 ± 188.98 0 ± 0 1040.21 ± 188.98
Stim 3.208 ± 0.794 6.75 ± 0.56 520.96 ± 53.5 −302.38 ± 107.36 823.34 ± 147.25
ENOB_13 Ctrl 126.88 ± 9.134 7.2 ± 0.19 9146.97 ± 894.84 0 ± 0 9146.97 ± 894.84
Stim 63.812 ± 11.828 6.7 ± 0.09 6385.87 ± 581.45 −2102.28 ± 277.56 8488.14 ± 527.53
ENOB_14 Ctrl 122.248 ± 8.739 8.32 ± 0.2 10182.92 ± 974.33 0 ± 0 10182.92 ± 974.33
Stim 18.397 ± 3.475 6.31 ± 0.16 4431.45 ± 265.25 −3461.71 ± 194.53 7893.16 ± 445.04
FHL1 Ctrl 0.029 ± 0.014 1.12 ± 0.13 0.34 ± 0.2 0 ± 0 0.34 ± 0.2
Stim 0.029 ± 0.022 0.82 ± 0.02 0.24 ± 0.15 −0.01 ± 0.34 0.24 ± 0.24
G3P Ctrl 7.465 ± 5.031 1.78 ± 0.01 133.04 ± 89.43 0 ± 0 133.04 ± 89.43
Stim 2.962 ± 0.954 0.73 ± 0 38.23 ± 15.29 −150.08 ± 197.24 188.32 ± 212.33
G3P_21 Ctrl 109.956 ± 7.694 1.46 ± 0.14 1613.36 ± 266.88 0 ± 0 1613.36 ± 266.88
Stim 46.649 ± 50.203 1.38 ± 0.25 1122.95 ± 605.54 −2110.24 ± 1439.57 3233.19 ± 862.22
G3P_22 Ctrl 38.481 ± 43.378 7.61 ± 0.18 2887.22 ± 3202.21 0 ± 0 2887.22 ± 3202.21
Stim 15.014 ± 3.308 6.68 ± 0.63 1855.18 ± 1626.69 −782.25 ± 1484.08 2637.43 ± 3108.14
HBA Ctrl 17.237 ± 0.806 7.22 ± 0.11 1243.23 ± 46.1 0 ± 0 1243.23 ± 46.1
Stim 47.533 ± 4.778 8.14 ± 0.22 2639.76 ± 282.65 1009.87 ± 147.66 1629.89 ± 150.76
HBB1 Ctrl 2.128 ± 1.269 5.6 ± 0.26 118.19 ± 70.19 0 ± 0 118.19 ± 70.19
Stim 4.543 ± 1.111 6.75 ± 0.22 225.26 ± 17.63 80.5 ± 78.44 144.75 ± 81.5
HBB2 Ctrl 1.274 ± 1.127 6.86 ± 0.5 85.82 ± 77.22 0 ± 0 85.82 ± 77.22
Stim 1.235 ± 0.526 6.08 ± 1.46 76.4 ± 29.18 −1.3 ± 51.95 77.7 ± 67.98
HINT1 Ctrl 4.597 ± 0.916 1.53 ± 0.24 70.73 ± 19.3 0 ± 0 70.73 ± 19.3
Stim 4.486 ± 0.713 1.41 ± 0.26 63.79 ± 10.13 −3.68 ± 46.57 67.47 ± 56.58
HSPB6 Ctrl 11.222 ± 1.729 2.49 ± 0.27 276.83 ± 13.17 0 ± 0 276.83 ± 13.17
Stim 19.072 ± 2.131 4.31 ± 0.31 649.46 ± 38.23 261.67 ± 28.4 387.79 ± 26.73
IDH3A Ctrl 11.921 ± 3.248 3.16 ± 0.16 380.38 ± 122.29 0 ± 0 380.38 ± 122.29
Stim 10.4 ± 0.726 3.87 ± 0.13 430.66 ± 38.97 −50.71 ± 126.53 481.37 ± 164.29
IDHP Ctrl 51.897 ± 4.565 5.24 ± 0.22 2725.77 ± 350.74 0 ± 0 2725.77 ± 350.74
Stim 50.702 ± 0.872 5.39 ± 0.3 2771.17 ± 299.85 −39.84 ± 125.14 2811 ± 424.06
KAD1 Ctrl 28.059 ± 4.147 1.76 ± 0.02 493.58 ± 74.94 0 ± 0 493.58 ± 74.94
Stim 29.437 ± 3.087 1.56 ± 0.12 445.81 ± 23.08 45.93 ± 165.84 399.88 ± 188.47
KCRB Ctrl 30.595 ± 10.302 5.75 ± 0.6 1791.07 ± 713.95 0 ± 0 1791.07 ± 713.95
Stim 10.018 ± 4.301 4.69 ± 0.43 969.71 ± 379.84 −685.9 ± 296.54 1655.61 ± 619.91
KCRM Ctrl 96.04 ± 13.516 4.67 ± 0.18 4494.59 ± 794.43 0 ± 0 4494.59 ± 794.43
Stim 87.555 ± 9.66 4.67 ± 0.11 4293.57 ± 634.8 −282.82 ± 152.48 4576.39 ± 763.69
KCRM_16 Ctrl 413.051 ± 36.2 5.27 ± 0.15 21782.28 ± 2488.87 0 ± 0 21782.28 ± 2488.87
Stim 198.73 ± 44.331 5.21 ± 0 15946.53 ± 2086.16 −7144.05 ± 287.86 23090.57 ± 1817.23
KCRM_17 Ctrl 423.389 ± 40.41 3.44 ± 0.22 14632.6 ± 2318.62 0 ± 0 14632.6 ± 2318.62
Stim 192.577 ± 22.55 3.57 ± 0.04 10977.08 ± 993.4 −7693.73 ± 615.67 18670.81 ± 1593.69
KCRS_18 Ctrl 450.377 ± 30.738 3.62 ± 0.08 16319.94 ± 1091.25 0 ± 0 16319.94 ± 1091.25
Stim 210.019 ± 58.468 4.81 ± 0.24 15911.32 ± 2667.71 −8011.93 ± 1242.93 23923.25 ± 1619.45
KCRS_19 Ctrl 431.301 ± 41.392 2.12 ± 0.02 9156.49 ± 802.23 0 ± 0 9156.49 ± 802.23
Stim 302.168 ± 42.54 4.51 ± 0.28 16547.62 ± 1006.77 −4304.43 ± 2789.78 20852.05 ± 1842.02
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Identifier Group ABD (μg) FSR (%/d) ASR (ng/d) ABR (ng/d) ADR (ng/d)
KPYM Ctrl 79.697 ± 10.195 2.36 ± 0.33 1892.16 ± 454.83 0 ± 0 1892.16 ± 454.83
Stim 87.21 ± 9.936 2.15 ± 0.1 1796.88 ± 278.44 250.44 ± 207.76 1546.43 ± 319.5
LDHA Ctrl 108.089 ± 6.786 11.53 ± 0.05 12457.11 ± 725.6 0 ± 0 12457.11 ± 725.6
Stim 108.93 ± 7.088 11.28 ± 0.05 12241.4 ± 731.2 28.03 ± 15.47 12213.37 ± 721.1
MDHC Ctrl 35.322 ± 1.773 3.67 ± 0.29 1295.17 ± 83.16 0 ± 0 1295.17 ± 83.16
Stim 59.694 ± 6.675 4.74 ± 0.15 2257.03 ± 242.6 812.4 ± 219.43 1444.64 ± 127.46
MDHM Ctrl 104.639 ± 10.927 10.37 ± 0.36 10864.93 ± 1420.18 0 ± 0 10864.93 ± 1420.18
Stim 101.162 ± 16.945 10.74 ± 0.19 11069.56 ± 1608.18 −115.92 ± 345.51 11185.47 ± 1407.81
MLRS_11 Ctrl 643.988 ± 47.953 2.79 ± 0.13 17917.39 ± 992.05 0 ± 0 17917.39 ± 992.05
Stim 48.939 ± 9.327 2.73 ± 0 9467.28 ± 770.76 −19834.97 ± 1295.96 29302.25 ± 2065.49
MLRS_12 Ctrl 1092.033 ± 88.234 1.63 ± 0.03 17845.66 ± 1726.12 0 ± 0 17845.66 ± 1726.12
Stim 546.79 ± 648.837 1.81 ± 0.12 14661.57 ± 4665.12 −18174.75 ± 22945.56 32836.33 ± 18692.55
MYG Ctrl 68.438 ± 4.668 2.31 ± 0.01 1582.6 ± 102.28 0 ± 0 1582.6 ± 102.28
Stim 92.796 ± 7.03 3.64 ± 0.14 2936.55 ± 322.12 811.93 ± 79.05 2124.62 ± 243.09
MYL1 Ctrl 3.3 ± 1.605 1.87 ± 0.09 62.21 ± 30.83 0 ± 0 62.21 ± 30.83
Stim 1.027 ± 0.041 1.64 ± 0.11 35.66 ± 14.22 −75.78 ± 52.15 111.45 ± 66.29
MYL1_10 Ctrl 538.363 ± 47.761 3.35 ± 0.31 18094.78 ± 3198.32 0 ± 0 18094.78 ± 3198.32
Stim 254.257 ± 49.148 3.34 ± 0 13224.96 ± 1413.62 −9470.19 ± 1587.13 22695.16 ± 2082.41
MYL1_8 Ctrl 433.414 ± 83.669 4.8 ± 0.01 20795.97 ± 3986.39 0 ± 0 20795.97 ± 3986.39
Stim 180.728 ± 100.254 4.55 ± 0.12 13953.58 ± 3498.09 −8422.84 ± 3334.77 22376.42 ± 4562.5
MYL1_9 Ctrl 569.734 ± 47.311 3.32 ± 0.05 18912.88 ± 1859 0 ± 0 18912.88 ± 1859
Stim 278.664 ± 64.528 3.21 ± 0.18 13567.32 ± 802.91 −9702.35 ± 2890.2 23269.67 ± 3278.51
ODPA Ctrl 23.355 ± 2.406 7.84 ± 0.27 1829.51 ± 191.95 0 ± 0 1829.51 ± 191.95
Stim 37.202 ± 8.219 8.71 ± 0.58 2651.43 ± 524.2 461.58 ± 297.93 2189.85 ± 289.56
PARK7 Ctrl 10.306 ± 1.133 1.33 ± 0.04 137.31 ± 15.06 0 ± 0 137.31 ± 15.06
Stim 10.538 ± 1.672 1.35 ± 0.21 139.58 ± 19.64 7.71 ± 49 131.86 ± 63.94
PFKAM Ctrl 23.761 ± 3.78 9.25 ± 1.23 2219.7 ± 570.49 0 ± 0 2219.7 ± 570.49
Stim 1.113 ± 0.354 8.15 ± 1.07 1023.69 ± 251.27 −754.96 ± 134.27 1778.64 ± 374.95
PGAM2 Ctrl 76.615 ± 4.639 5.38 ± 0.36 4131.95 ± 527.36 0 ± 0 4131.95 ± 527.36
Stim 79.621 ± 15.464 5.17 ± 0.4 4069.18 ± 828.78 100.22 ± 366.07 3968.97 ± 473.77
PGK1 Ctrl 101.157 ± 5.766 6.53 ± 0.33 6588.74 ± 39.8 0 ± 0 6588.74 ± 39.8
Stim 116.618 ± 15.583 5.6 ± 0.34 6117.53 ± 973.99 515.38 ± 330.12 5602.16 ± 649.8
PGM1 Ctrl 35.586 ± 6.006 3.5 ± 0.2 1254.24 ± 281.39 0 ± 0 1254.24 ± 281.39
Stim 55.338 ± 7.558 2.33 ± 0.22 1060.55 ± 86.56 658.77 ± 446.46 402.17 ± 524.73
PLEC_2 Ctrl 992.955 ± 85.984 0.56 ± 0.12 5583.69 ± 1705.98 0 ± 0 5583.69 ± 1705.98
Stim 452.594 ± 93.357 0.94 ± 0.05 6795.43 ± 947.86 −18012.03 ± 333.63 24807.46 ± 856.1
PRVA Ctrl 4.654 ± 0.666 4.5 ± 0.3 209.47 ± 35.09 0 ± 0 209.47 ± 35.09
Stim 4.313 ± 0.872 4.09 ± 0.29 183.53 ± 16 −11.38 ± 51.08 194.91 ± 49.66
PYGB Ctrl 57.895 ± 5.111 11.72 ± 0.97 6786.96 ± 793.09 0 ± 0 6786.96 ± 793.09
Stim 22.199 ± 6.615 9.32 ± 1.49 3763.21 ± 899.76 −1189.85 ± 291.2 4953.07 ± 755.75
PYGM Ctrl 186.593 ± 22.567 9.39 ± 0.41 17552.12 ± 2630.16 0 ± 0 17552.12 ± 2630.16
Stim 189.128 ± 19.35 9.26 ± 0.39 17430.1 ± 2460.82 84.65 ± 483.34 17345.61 ± 2523.06
SAFB1 Ctrl 91.894 ± 5.005 0.98 ± 0 902.23 ± 50.35 0 ± 0 902.23 ± 50.35
Stim 76.542 ± 20.555 1.24 ± 0.21 1027.89 ± 91.89 −511.73 ± 576.74 1539.62 ± 603.2
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CLFS was associated with proteoform-specific changes 
to the fast-twitch isoform of skeletal muscle myosin reg-
ulatory light chain (MLRS). Two proteoforms MLRS_11 
and MLRS_12 were identified by 2DGE (Figure S1). The 
abundance of MLRS_12 was not altered by CLFS whereas 
MLRS_11 abundance decreased at a rate of 19.84  μg/ d 
from 644  μg in Ctrl to 49  μg in Stim during the course 
of the 30-day experiment. The difference in MLRS_11 
ASR between Stim (9.47 μg/d) and Ctrl (17.92 μg/d) was 
8.45  μg/d. Whereas the difference in MLRS_11 ADR 
between Stim (29.30  μg/d) and Ctrl (17.92  μg/d) was 
11.39  μg/d (Figure  2F). Therefore, the 8.45  μg/d lesser 
ASR combined with the 11.39 μg/d increase in ADR ac-
counts for the 19.385  μg/d change in MLRS_11 abun-
dance. In percentage terms, the contribution of the change 
in synthesis to the change in abundance was 42.6% and the 
contribution of degradation to the change in abundance 
was 57.4%. Site-specific posttranslational modifications 
of MLRS were investigated by LC-MS/MS analysis of 
MLRS_11 and MLRS_12. A sequence coverage of 92% 
(MOWSE score 1770) was achieved and searches of the 
MS/MS spectra (Supporting Information) unambiguously 
identified S16 phosphorylation in both MLRS_11 and 
MLRS_12. In addition, MLRS_11 contained an additional 
site-specific phosphorylation of S20 (Figure  S2) and a 
di-glycine remnant on K137 (Figure S3) that were not de-
tected in MLRS_12.
The relative contribution of synthesis and degradation to 
changes in protein abundance differed on a protein-by-protein 
basis and between each 10-d interval within the 30-d exper-
imental period. Figure 3 illustrates the relative contributions 
of synthesis and degradation to changes in protein abundance 
between day 0 and day 10 (Figure 3A,B), day 10 and day 20 
(Figure 3C,D), or between day 20 and day 30 (Figure 3E,F). 
On average protein degradation accounted for 64.34% of 
the change in protein abundance between day 0 and day 10, 
whereas the contribution of degradation was 54.52% between 
day 10 and day 20, and the contribution of degradation was 
53.47% between day 20 and day 30 of CLFS. The contribution 
of degradation to changes in the abundance of individual pro-
teins was different during each 10-d period of the experiment. 
The majority of the change in MLRS_11 abundance was com-
plete after 20 days CLFS. The abundance (41.31 ± 36.37 μg) 
of MLRS_11 was significantly (P = .00106) less than control 
(235.05 ± 15.38 μg) after 20 days of CLFS. During the period 
between 10 and 20 days (Figure 3C,D) the difference in deg-
radation between Ctrl and Stim EDL accounted for 92.7% of 
the change in MLRS_11 abundance.
Identifier Group ABD (μg) FSR (%/d) ASR (ng/d) ABR (ng/d) ADR (ng/d)
TNNI1_24 Ctrl 487.755 ± 40.23 3.35 ± 0.04 16344.8 ± 1555.22 0 ± 0 16344.8 ± 1555.22
Stim 457.121 ± 169.884 3.86 ± 0.36 18019.22 ± 2339.75 −1021.14 ± 4322.32 19040.36 ± 2042.32
TNNI2_23 Ctrl 609.748 ± 50.768 4.29 ± 0.01 26179.54 ± 2109.51 0 ± 0 26179.54 ± 2109.51
Stim 133.773 ± 45.309 2.22 ± 0.53 8156.02 ± 1254.36 −15865.83 ± 2206.8 24021.85 ± 1558.17
TNNT1_27 Ctrl 982.272 ± 82.957 1.36 ± 0.42 13591.82 ± 5319.01 0 ± 0 13591.82 ± 5319.01
Stim 554.652 ± 326.11 2.19 ± 0.15 16976.49 ± 4704.14 −14254 ± 10451.25 31230.49 ± 7296.49
TNNT3_25 Ctrl 779.237 ± 65.412 2.66 ± 0.06 20716.24 ± 1262.76 0 ± 0 20716.24 ± 1262.76
Stim 301.783 ± 162.126 2.47 ± 0.03 13321.96 ± 2567.46 −15915.15 ± 3679.44 29237.11 ± 1737.41
TNNT3_26 Ctrl 606.31 ± 88.137 1.83 ± 0.1 11114.15 ± 1631.94 0 ± 0 11114.15 ± 1631.94
Stim 187.44 ± 12.098 0.75 ± 0 2958.49 ± 323.68 −13962.33 ± 3045.91 16920.83 ± 3358.22
TNNT3_28 Ctrl 644.558 ± 53.776 1.64 ± 0.15 10642.15 ± 1880.09 0 ± 0 10642.15 ± 1880.09
Stim 148.006 ± 11.68 1.18 ± 0.46 4764.17 ± 2186.4 −16551.73 ± 1668.5 21315.9 ± 3854.9
TPIS Ctrl 58.074 ± 3.245 2.05 ± 0.04 1187.22 ± 42.24 0 ± 0 1187.22 ± 42.24
Stim 12.737 ± 2.265 0.93 ± 0.02 327.55 ± 18.18 −1511.24 ± 65.93 1838.79 ± 75.84
TPM2_7 Ctrl 3363.008 ± 293.726 1.31 ± 0.08 44066.39 ± 6466.91 0 ± 0 44066.39 ± 6466.91
Stim 1539.928 ± 278.791 1.39 ± 0.08 34157.75 ± 4805.09 −60769.34 ± 3955.03 94927.09 ± 5386.44
TPM4_6 Ctrl 3146.903 ± 311.36 9.32 ± 0.29 292795.95 ± 20066.72 0 ± 0 292795.95 ± 20066.72
Stim 1521.797 ± 136.055 9.1 ± 0.1 212405.22 ± 19859.46 −54170.21 ± 5924.03 266575.42 ± 25624.58
VDAC Ctrl 31.607 ± 1.529 1.56 ± 0.02 493.74 ± 27.07 0 ± 0 493.74 ± 27.07
Stim 32.247 ± 4.065 1.52 ± 0.26 482.47 ± 49.62 21.33 ± 134.62 461.14 ± 169.18
Note: Identifier represents the UniProt identifier and 2DGE spot number of each proteoform, Total abundance (ABD) is presented (μg). Fractional synthesis rate (FSR, 
%/d) was calculated across 0, 10, 20 and 30 days using Equation (3). Absolute rate of abundance change (ABR), synthesis (ASR) and degradation (ADR) are presented 
in ng/d.
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4 |  DISCUSSION
We report novel data on the absolute rates (ng/d) of protein 
synthesis, abundance-change and degradation in muscle un-
dergoing adaptation to a chronic exercise stimulus in vivo. 
Proteo-ADPT offers new insight to the processes that result 
in changes in protein abundance and, therefore, muscle func-
tion induced by chronic endurance activity. Alterations to 
the abundance of key myofibrillar and metabolic enzymes in 
exercised muscle were underpinned by significant changes 
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to the rates of both synthesis and degradation (Figure  2). 
Moreover, the relative contributions of synthesis and degra-
dation to protein-by-protein changes in abundance were dif-
ferent during early, mid and late periods of the experimental 
intervention (Figure 3). In response to CLFS, fast-twitch EDL 
muscle transformed to a slower more oxidative phenotype 
through decreases in the abundance of glycolytic enzymes 
and fast isoforms of myofibrillar proteins and cooccurring 
increases in mitochondrial proteins and slow myofibrillar 
protein-isoforms. The contribution of protein degradation 
to changes in muscle protein abundance averaged 49% and 
some changes in protein abundance were almost entirely due 
to a change in protein degradation, rather than a change in 
protein synthesis. The ability to identify which changes in 
protein abundance are primarily mediated by either synthetic 
or degradative processes provides new opportunities for fu-
ture work linking regulatory mechanisms, such as ubiquitina-
tion, with signal transduction processes and the expression of 
ubiquitin E3 ligases.
Muscle adaptations to endurance training occur gradually 
and involve the activation of signaling networks and gene 
expression programes that result in long-term changes in 
muscle phenotype. The outcomes of endurance training, in-
cluding changes to muscle substrate utilization and mitochon-
drial content are well established26 but the acute and chronic 
responses of the muscle proteome to exercise differ27,28 and 
cannot easily be reconciled. Early signaling responses to 
acute exercise29 and the subsequent changes in gene expres-
sion20 have been investigated in detail. Whereas, the inter-
vening processes that join acute responses of each individual 
bout of exercise into cumulative adaptation have not received 
so much attention. In humans, changes in the abundance of 
proteins and mRNA after a chronic period of training cor-
relate poorly20 and mRNA responses to acute exercise do not 
predict longer term adaptations of the muscle proteome.30 
These findings resonate with acknowledged discrepancies 
between the abundance of proteins and the expression of 
their mRNA in model organisms.31 Data from mammalian 
cells in vitro32 report the generally poor correlation between 
mRNA and protein can only be resolved when both pro-
tein synthesis and degradation rates are taken in to account. 
Proteo-ADPT enables the synthesis-abundance-degradation 
relationship of proteins to be studied so that the contribution 
of protein degradation can be assessed in vivo and may be 
key in linking cell signaling events to protein degradative 
processes. The ubiquitin proteasome system is established as 
a regulatory mechanism influencing the abundance of short-
lived proteins, including the myogenic transcription factor, 
Myo D 1.33 Substrates of key ubiquitin E3 ligases in muscle, 
including atrogin-134 and MuRF1,35 have been reported, but 
there are >1,400 E3 ubiquitin-protein ligases and >800 au-
tophagy-related proteins annotated in the Human SwissProt 
database. The ubiquitin proteasome36 and autophagy37 sys-
tems are established components in the adaptation of muscle 
to exercise, and acute exercise causes widespread changes in 
protein ubiquitination.38 The contribution of protein-specific 
degradation to exercise-induced changes in the profile of 
abundant muscle proteins has seldom been reported but this 
information will be essential to further understanding of the 
health benefits of exercise.
Recently, we5,39 developed dynamic proteome profiling 
(DPP) and investigated protein-specific responses of human 
muscle to resistance training10 and rat muscle to endurance 
activity.40 In the current work, we have calculated absolute 
(ng) values and used time series analysis41 to exclude proteins 
that fitted poorly (R2  <  0.85) to the expected exponential 
decay in peptide monoisotopic peak abundance. These meth-
odological developments have enabled us to interrogate each 
10-d interval with confidence and reveal time-dependent 
differences in the contributions of synthesis and degradation 
to add further detail to exercise-induced changes in protein 
abundance and synthesis rate. We report a 2.69-fold increase 
(P =  .0044 BH-corrected) in ATPA abundance (Figure 1F) 
and a 120% increase in the FSR of ATPA from 1.44 ± 0.23 
to 3.16 ± 0.03%/d in EDL exposed to 30-d CLFS (Figure 2). 
These data derived from our extreme model of change give 
insight to how adaptation of ATPA might be orchestrated 
in the context of endurance exercise. For example, our re-
cent analysis of voluntary free-wheel running 40 reported a 
28% increase in the FSR of ATPA from 1.86 ± 0.07%/d to 
2.38 ± 1.3%/d in rat slow-twitch muscle. Free-wheel running 
is a mild training stimulus and did not alter ATPA protein 
abundance40 but increases in the abundance of ATP synthase 
subunits are a common finding in proteomic studies of mod-
erate to intense endurance training.27 However, based on FSR 
data alone, it is not possible to interpret how the increase in 
F I G U R E  3  Temporal differences in the contribution of protein degradation to changes in the abundance of individual proteins. Scatter plots 
reporting the percent contribution of degradation to changes in protein abundance presented as the rate (ng/d) of change in abundance expressed 
as a percentage of average protein abundance during (A) 0 and 10 days, (C) 10 and 20 days or (E) 20 and 30 days periods of CLFS. Box plots 
reporting the rates (ng/d) of change in abundance (ABR), absolute synthesis rate (ASR), absolute degradation rate (ADR) and FSR (%/d) for 
select proteins (ATPB, ATP synthase subunit beta; ENOB, beta enolase; IDHP, isocitrate dehydrogenase; MLRS, myosin regulatory light chain 
2; PFKAM, ATP-dependant 6-phosphofructokinase; TPIS, triosephosphate isomerase) during (B) 0 and 10 days, (D) 10 and 20 days or (F) 20 and 
30 days periods of CLFS. Proteins are labeled by their UniProt identifier in panels A, C and E. Panel A reports proteins that differed in abundance 
at a significance level of P < .1, whereas panels C and E report proteins that changed in abundance at a significance level of P < .05 after BH-
correction
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ATPA synthesis contributed to the gain in ATPA abundance. 
Nor is it clear whether a change in ATPA degradation rate may 
have contributed to or detracted from the synthetic response. 
In the current study, we equate FSR measurements with abso-
lute protein abundance data and report the 7.6 ± 0.3 μg/d gain 
in ATPA abundance was almost entirely accounted for by the 
greater (P = .0072 BH-corrected) synthesis of ATPA in Stim 
(6.3  ±  0.9  μg/d) than Ctrl (1.2  ±  0.2  μg/d) muscle, and a 
decline in protein degradation contributed to rather than de-
tracted from this response.
Our DPP study10 on human muscle responses to resis-
tance exercise highlighted several different patterns among 
the synthesis, abundance, and degradation responses of in-
dividual proteins. For example, glyceraldehyde-3-phosphate 
dehydrogenase (G3P) and triosephosphate isomerase (TPIS) 
decreased in abundance without exhibiting a decrease in FSR, 
whereas the significant decrease in beta-enolase (ENOB) 
abundance in resistance-trained muscle occurred alongside a 
significant increase in ENOB synthesis rate.10 These findings 
warranted further investigation on the role and regulation of 
protein degradation in exercise-induced muscle adaptation. 
Using Proteo-ADPT, we report instances where the differ-
ence in protein degradation almost entirely accounted for the 
change in protein abundance. For example, during the first 
10 days of CLFS the lesser degradation of ATPB was respon-
sible for 82% of the gain in ATPB abundance. The turnover 
(7.9 ± 0.98 μg/d) of ATPB was stable in Ctrl muscle, whereas 
ATPB synthesis increased to 8.74 ± 0.5 μg/d in Stim muscle 
and degradation decreased to 4.62 ± 0.55 μg/d resulting in 
a gain (P =  .012) in ATPB abundance from 87.3 ± 6.8 μg 
to 127.9 ± 14.6 μg. Notably, the FSR of ATPB was greater 
in Ctrl (9.16 ± 1.04%/d) than Stim (8.15 ± 0.57%/d) mus-
cle (Figure  3D). Indeed, 20% of proteins studied exhibited 
opposite changes in FSR and ASR in Stim muscle during 
the course of the 30-d intervention (Table 2). These 
observations serve to highlight the challenges of interpret-
ing protein-specific FSR data in isolation, and the added 
benefits of calculating absolute data on the total abundance 
change, synthesis rate and degradation rate of individual 
proteins.
Muscle responses to endurance exercise in rats2 and hu-
mans3 include changes to the proteoform abundance of myo-
fibrillar and metabolic proteins that may indicate differences 
in the expression or posttranscriptional processing of splice 
variants or changes to the posttranslational state of proteins.21 
Our current 2DGE analysis of myofibrillar proteins discov-
ered proteoform-specific differences in the basal rate of turn-
over among proteoforms in Ctrl muscle, and differences in 
the contributions of synthesis and degradation to changes in 
proteoform abundance in Stim muscle. We report a di-glycine 
remnant on K137 and phosphorylation of S20 of myosin regu-
latory light chain (MLRS) are associated with the reduction in 
MLRS_11 abundance that was primarily driven by a greater 
rate of degradation in Stim muscle. Ubiquitination of MLRS 
K137 has previously been reported42 in mouse muscle under-
going denervation-induced atrophy and was not detected in 
innervated control samples. Cross-talk exists between phos-
phorylation and ubiquitination in exercised muscle38 and 
phosphorylation of MLRS has previously been associated 
with age-related decline in muscle function.43 Therefore, our 
findings point to a potential link between S20 phosphorylation 
and ubiquitination of K137 that warrants further investigation. 
Bottom-up analysis of peptides enriched using anti-diglycine 
remnant (K-ε-GG) Ab44 and titanium dioxide22 could provide 
more comprehensive insight to site-specific changes in ubiq-
uitination and phosphorylation, respectively. Nevertheless, 
top-down analyses will also be required to capture the unique 
combinations of covalent modifications that cooccur among 
different regions of each protein. In addition, it will be im-
portant to characterize the topology23 and posttranslational 
modification45 of polyubiquitin chains anchored to specific 
protein residues to fully understand the biological conse-
quences of the protein modifications.
Thirty days CLFS reduced the size of Stim EDL to 50% 
of Ctrl (Figure 1A). Previously, we13 reported a similar loss 
in EDL mass after 56 days of CLFS was associated signifi-
cant changes to the myofiber profile and functional charac-
teristics of rat EDL. Maximum isometric force decreased to 
40% of control and time to peak isometric tension increased 
by 54%, resulting in a ~ 74% decrease in maximum power 
of transformed EDL. After 56 days of CLFS, the changes in 
muscle function coincided with a significant increase in the 
proportion of Type I fibers and decreases in the proportion 
and cross-sectional area of Type IIB fibers in stimulated mus-
cle.13 There was no evidence of muscle damage after 9 or 56 
days CLFS13 and in our current work we report decreases in 
the absolute abundance of metabolic enzymes and slow- as 
well as fast- myofibrillar isoforms that account for up to 90% 
of the decline in muscle protein content. Our current analy-
sis was limited to highly abundant proteins but nevertheless 
did not include collagens, which are an important compo-
nent of the skeletal muscle extracellular matrix.46 Onward 
development of Proteo-ADPT using more advanced mass 
spectrometry platforms may need to consider sample prepa-
ration methods suitable for muscle collagens. Alternatively, 
fractionation may be required to distinguish the cell-specific 
origin of newly synthesized collagen peptides.
Pette et al47 also reported reciprocal changes in MyHC 
IIb and MyHC IIa in Stim rat EDL. After 30 days CLFS. The 
relative abundance of MyHC IIa increased from ~18% to 46% 
and MyHC IIb abundance decreased from  ~47% to  ~16%, 
whereas the increase in MyHC I from ~5% to ~8% was less 
prominent.47 Herein, we report the emergence of slow iso-
forms of myosin light chains and troponin subunits (Table 1) 
consistent with earlier histochemical13 and biochemical47 
findings. Our current analysis also adds significant detail 
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to the mechanisms underpinning the previously observed 
changes in myofiber profile. For example, between 10 and 
20 days CLFS the greater degradation of a proteoform of the 
slow skeletal isoform of troponin I (TNNI1_24) accounted for 
97% of the decrease in TNNI1_24 abundance in Stim EDL. 
Whereas a decrease in synthetic rate accounted for 65% of 
the decrease in the abundance of the fast isoform of troponin 
T (TNNT3_28), which likely reflects expected decreases in 
fast troponin T gene expression.48 Mayne et al49, reports the 
appearance of slow twitch myosin light chain isoforms in rat 
EDL after 61 days CLFS. Herein, we reveal emergent slow 
isoforms of myofibrillar proteins (Table 1) were not spared 
from degradation and their rate of synthesis exceeded the rate 
of gain in abundance. This pattern of response agrees closely 
with the observation50 that the increase in relative abundance 
of MyHC IIa during the first 15 days of CLFS lags behind 
the rate of increase in the incorporation of 35S-methionine 
in to the IIa MyHC pool. Our protein abundance data also 
concur with proteomic profiling51 of rabbit fast-twitch mus-
cle responses to CLFS that report a transition from fast to 
slow isoforms of myofibrillar proteins alongside decreases in 
glycolytic enzymes and increases in mitochondrial proteins. 
Moreover, the emergence of CRYAB and MLRV in Stim 
EDL (Table  1) is consistent with our findings in the fast-
twitch plantaris muscle of endurance-trained rats.2 The emer-
gence of CRYAB among the myofibrillar fraction is similar 
to the response in resistance trained human muscle10 and 
may be associated with a protective effect evoked by muscle 
contraction.52
In conclusion, we provide empirical data on the contri-
bution of protein degradation and protein synthesis to phys-
iological adaptation of skeletal muscle. Over the course of 
the 30 days CLFS intervention, protein degradation made 
a 49% contribution to the changes in muscle protein abun-
dance. Generally, proteins that decreased in abundance had 
a greater contribution of degradation to the change in abun-
dance. However, some proteins decrease in abundance with 
very little change in degradation rate, that is, the decrease 
in protein synthesis almost fully explained the decrease in 
abundance. Conversely, the increased abundance of some 
proteins was primarily due to a lesser rate of degradation 
rather than a greater rate of synthesis. Muscle adaptations 
to endurance exercise underpin many of the health benefits 
of a physically active lifestyle. Nevertheless, the processes 
governing changes in protein abundance are incompletely 
understood. Proteo-ADPT provides unique insight to the 
contributions of synthetic and degradative processes to ex-
ercise-induced changes in protein abundance. This informa-
tion can be used to link signaling events to the control of 
either synthetic or degradative effects and to resolve dis-
parities between studies that measure gene expression and 
studies that measure changes in protein abundance in re-
sponse to exercise.
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